Young‐onset dementia (YOD), defined as dementia with onset between 40 and 65 years of age, is an emerging global health concern associated with substantial healthcare and socioeconomic burdens. Using data from the Global Burden of Disease Study 2021, this population‐based study analyzed trends in the prevalence, deat...
Yang Zhao, Tai-Yi Sun, Rui Zhang et al.· Brain Health· 0 citations
BackgroundDemyelination and remyelination are critical processes in the pathogenesis of Alzheimer's disease (AD). The selective estrogen receptor modulator bazedoxifene (BZA) has been shown to promote remyelination, suggesting its potential therapeutic efficacy.ObjectiveThis study aimed to evaluate the therapeutic effi...
Man-Yu Xu, Yu-Di Bai, Xiao-Qin Zeng et al.· Journal of Alzheimer's Disea...· 0 citations
OBJECTIVE
Recent studies suggest that combining plasma phosphorylated tau (p-tau) with β-amyloid (Aβ) may improve diagnosis accuracy for Alzheimer's disease (AD). However, the cross-sectional and longitudinal concordance of these markers with Aβ positron emission tomography (PET) positivity remains incompletely underst...
Mingxing Jiang, Guo-Yu Lan, Jiayi Zhu et al.· Annals of Neurology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.